Safety of Intravitreal Injection of Biosimilar of Aflibercept in Rabbit Eyes.

Alireza LashayHamid Riazi-Esfahani Hooshang FaghihiAhmad MirshahiHassan KhojastehAlireza KhodabandeFahimeh Asadi AmoliFariba GhassemiFatemeh BazvandElias Khalili PourNazanin EbrahimiadibAli TorkashvandElham Delrish

Published in: Journal of ophthalmology (2020)

The 2 mg intravitreal injection of biosimilar aflibercept (CinnaGen Co., Iran) was found to be nontoxic in rabbit eyes in the short-term period. Further studies are required to warrant the efficacy and safety profile of the drug in human subjects.

Keyphrases

age related macular degeneration
optical coherence tomography
diabetic retinopathy
vascular endothelial growth factor
endothelial cells
ultrasound guided
induced pluripotent stem cells
cataract surgery
pluripotent stem cells
case control